| Literature DB >> 24186934 |
Andriy Yabluchanskiy1, Yonggang Ma, Rugmani Padmanabhan Iyer, Michael E Hall, Merry L Lindsey.
Abstract
Matrix metalloproteinase (MMP)-9, one of the most widely investigated MMPs, regulates pathological remodeling processes that involve inflammation and fibrosis in cardiovascular disease. MMP-9 directly degrades extracellular matrix (ECM) proteins and activates cytokines and chemokines to regulate tissue remodeling. MMP-9 deletion or inhibition has proven overall beneficial in multiple animal models of cardiovascular disease. As such, MMP-9 expression and activity is a common end point measured. MMP-9 cell-specific overexpression, however, has also proven beneficial and highlights the fact that little information is available on the underlying mechanisms of MMP-9 function. In this review, we summarize our current understanding of MMP-9 physiology, including structure, regulation, activation, and downstream effects of increased MMP-9. We discuss MMP-9 roles during inflammation and fibrosis in cardiovascular disease. By concentrating on the substrates of MMP-9 and their roles in cardiovascular disease, we explore the overall function and discuss future directions on the translational potential of MMP-9 based therapies.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24186934 PMCID: PMC3858212 DOI: 10.1152/physiol.00029.2013
Source DB: PubMed Journal: Physiology (Bethesda) ISSN: 1548-9221